https://sputnikglobe.com/20221006/indian-made-cough-syrups-could-be-linked-to-death-of-66-children-in-gambia-who-warns-1101558335.html
Indian-Made Cough Syrups Could Be Linked to Death of 66 Children in Gambia, WHO Warns
Indian-Made Cough Syrups Could Be Linked to Death of 66 Children in Gambia, WHO Warns
Sputnik International
The Indian government has already initiated a probe, taking up the matter with the health regulators. According to health officials, the manufacturers did not... 06.10.2022, Sputnik International
2022-10-06T07:38+0000
2022-10-06T07:38+0000
2023-02-14T12:24+0000
world health organization (who)
world health organization
health
children
africa
west africa
https://cdn1.img.sputnikglobe.com/img/107840/93/1078409339_0:0:1920:1080_1920x0_80_0_0_461c4854828688d789c317fee8b08129.jpg
The World Health Organization (WHO) has issued a warning targeting four Indian-manufactured cough syrups, suggesting that they "have been potentially linked with acute kidney injuries and 66 deaths among children" in Gambia.Manufactured by Maiden Pharmaceutical Limited in Haryana state's Sonepat district, the four cough syrups include Promethazine Oral Solution, Kofexmalin Baby Cough Syrup, Makoff Baby Cough Syrup, and Magrip N Cold Syrup."Laboratory analysis of samples of each of the four products confirms that they contain unacceptable amounts of diethylene glycol and ethylene glycol as contaminants," the WHO alert said.A source told The Times of India that the Central Drugs Standard Control Organization immediately took up the matter with the Haryana state regulatory authority.However, the "exact one-to-one causal relation of death" has not yet been provided by the WHO, it added.
https://sputnikglobe.com/20220809/metropolitan-countries-attempt-to-return-to-african-continent-in-terms-of-control-expert-says-1099421351.html
africa
west africa
Sputnik International
feedback@sputniknews.com
+74956456601
MIA „Rossiya Segodnya“
2022
Sangeeta Yadav
https://cdn1.img.sputnikglobe.com/img/07e4/08/1b/1080292803_0:121:960:1081_100x100_80_0_0_7490b319dab9611e309056b177265184.jpg
Sangeeta Yadav
https://cdn1.img.sputnikglobe.com/img/07e4/08/1b/1080292803_0:121:960:1081_100x100_80_0_0_7490b319dab9611e309056b177265184.jpg
News
en_EN
Sputnik International
feedback@sputniknews.com
+74956456601
MIA „Rossiya Segodnya“
https://cdn1.img.sputnikglobe.com/img/107840/93/1078409339_0:0:1920:1440_1920x0_80_0_0_57db1e96c236d72d713c19d381eb85f6.jpgSputnik International
feedback@sputniknews.com
+74956456601
MIA „Rossiya Segodnya“
Sangeeta Yadav
https://cdn1.img.sputnikglobe.com/img/07e4/08/1b/1080292803_0:121:960:1081_100x100_80_0_0_7490b319dab9611e309056b177265184.jpg
world health organization (who), world health organization, health, children, west africa
world health organization (who), world health organization, health, children, west africa
Indian-Made Cough Syrups Could Be Linked to Death of 66 Children in Gambia, WHO Warns
07:38 GMT 06.10.2022 (Updated: 12:24 GMT 14.02.2023) The Indian government has already initiated a probe, taking up the matter with the health regulators. According to health officials, the manufacturers did not provided guarantees on the safety and quality of their products to the international body.
The World Health Organization (WHO) has issued a warning targeting four Indian-manufactured cough syrups, suggesting that they "have been potentially linked with acute kidney injuries and 66 deaths among children" in Gambia.
Manufactured by Maiden Pharmaceutical Limited in Haryana state's Sonepat district, the four cough syrups include Promethazine Oral Solution, Kofexmalin Baby Cough Syrup, Makoff Baby Cough Syrup, and Magrip N Cold Syrup.
"Laboratory analysis of samples of each of the four products confirms that they contain unacceptable amounts of diethylene glycol and ethylene glycol as contaminants," the WHO alert said.
"Toxic effects can include abdominal pain, vomiting, diarrhoea, inability to pass urine, headache, altered mental state, and acute kidney injury which may eventually lead to death," WHO alert said.
A source told The Times of India that the Central Drugs Standard Control Organization immediately took up the matter with the Haryana state regulatory authority.
However, the "exact one-to-one causal relation of death" has not yet been provided by the WHO, it added.